Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
C

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymphoma

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
37 views
August 15, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Hodgkin Lymphoma
20:26

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

2018 Pan Pacific Lymphoma Conference

R. Hoppe

28 views
10:00

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

56 views
15:48

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

37 views
21:11

Use of Total Metabolic Tumor Volume in PET Scans

2018 Pan Pacific Lymphoma Conference

N. Hansen

137 views
06:45

Hodgkin Lymphoma: First Relapse Options

2018 Pan Pacific Lymphoma Conference

B. Pro

87 views
16:04

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

2018 Pan Pacific Lymphoma Conference

B. Pro

255 views
20:54

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

2018 Pan Pacific Lymphoma Conference

S. Ansell

40 views
14:48

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

2018 Pan Pacific Lymphoma Conference

A. Engert

29 views